title: [Hemodynamics, electrophysiological parameters of the heart and differential therapy of attacks of atrial fibrillation in patients with subclinical thyroid dysfunction].
abstract: Thirty patients with subclinical thyrotoxicosis and 32 with subclinical hypothyroidism with attacks of atrial fibrillation were investigated. At levels of thyroid-stimulating hormone below 0.1 or above 10.0 mIU/l average triiodothyronine and thyroxine levels in patients with subclinical thyrotoxicosis were 89.6 and 73.2%, respectively, higher than in patients with subclinical hypothyroidism. Some relationships were found between levels of thyroid hormones and hemodynamic and electrophysiological parameters of the heart. Differential therapy of attacks of atrial fibrillation was effective in 80 and 62.5% of patients with subclinical thyrotoxicosis or hypothyroidism, respectively.
authors.forename: F K
authors.initials: FK
authors.lastname: Rachmatullov
authors.forename: L A
authors.initials: LA
authors.lastname: Bondarenko
authors.forename: A M
authors.initials: AM
authors.lastname: Bibarsova
authors.forename: V Iu
authors.initials: VIu
authors.lastname: Kapelovich
authors.forename: V V
authors.initials: VV
authors.lastname: Osipova
authors.forename: A N
authors.initials: AN
authors.lastname: Karakina
authors.forename: E G
authors.initials: EG
authors.lastname: Zinov'eva
authors.forename: I P
authors.initials: IP
authors.lastname: Tatarchenko
mesh_terms: D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000627:therapeutic use; D013956:Antithyroid Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000097:blood / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D003627:Data Interpretation, Statistical; D004452:Echocardiography; D004562:Electrocardiography; D004594:Electrophysiology; D005260:Female; D006439:Hemodynamics; D006801:Humans; D007037:Hypothyroidism / Q000150:complications / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D013959:Thyroid Diseases / Q000097:blood / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D013963:Thyroid Hormones / Q000097:blood; D013971:Thyrotoxicosis / Q000150:complications / Q000503:physiopathology; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D013997:Time Factors; D014284:Triiodothyronine / Q000097:blood
chemical_list: D000889:Anti-Arrhythmia Agents; D013956:Antithyroid Agents; D013963:Thyroid Hormones; D014284:Triiodothyronine; D013972:Thyrotropin; D013974:Thyroxine